San Diego, CA, United States of America

Meng Yang

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2003-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Meng Yang

Introduction

Meng Yang is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in cancer treatment and angiogenesis research. With a total of eight patents to his name, his work has the potential to impact medical science profoundly.

Latest Patents

Among his latest patents is the invention of cancer selective auxotrophs. These bacteria are auxotrophic for at least two amino acids found in tumors, making them effective anti-tumor treatments, labeling agents, and vaccines against infections. Improved antitumor effects can be achieved by passing these strains through an appropriate tumor model. Another notable patent involves angiogenesis models using nestin-expressing stem cells to image nascent blood vessels. This invention highlights nestin expression as a marker for endothelial cell proliferation, particularly useful in modeling tumor-related angiogenesis.

Career Highlights

Meng Yang has worked with various companies, including Anticancer, Inc. His innovative research and patents have positioned him as a key figure in the biotechnology sector. His work continues to inspire advancements in cancer therapies and related fields.

Collaborations

Meng Yang has collaborated with notable professionals in his field, including Ping Jiang and Lingna Li. These partnerships have contributed to the success and development of his innovative projects.

Conclusion

Meng Yang's contributions to biotechnology and cancer research are noteworthy. His patents and collaborations reflect his commitment to advancing medical science and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…